Cargando…
Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
Background: Ovarian cancer has a low incidence, but high mortality due to a habitual diagnosis in advanced cancer stages. Currently, used biomarkers have good sensitivity, but low specificity. Aim: To determine the usefulness of the biomarkers and algorithms used up to now in the screening, diagnosi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624892/ https://www.ncbi.nlm.nih.gov/pubmed/34834467 http://dx.doi.org/10.3390/jpm11111115 |
_version_ | 1784606284893388800 |
---|---|
author | Elorriaga, Miguel Ángel Neyro, José Luis Mieza, Jon Cristóbal, Ignacio Llueca, Antoni |
author_facet | Elorriaga, Miguel Ángel Neyro, José Luis Mieza, Jon Cristóbal, Ignacio Llueca, Antoni |
author_sort | Elorriaga, Miguel Ángel |
collection | PubMed |
description | Background: Ovarian cancer has a low incidence, but high mortality due to a habitual diagnosis in advanced cancer stages. Currently, used biomarkers have good sensitivity, but low specificity. Aim: To determine the usefulness of the biomarkers and algorithms used up to now in the screening, diagnosis, response to treatments and identification of recurrence in patients with ovarian masses. Methodology: Systematic search of publications in English in the Medline-PubMed database with the terms: “biomarkers”, “tumour”, “tumour biomarkers”, “marker”, “tumour marker”, “ovarian cancer”, “ovarian”, “Neoplasms”, “cancer”, CA-125 Antigen; Human Epididymis-specific Protein E4; Risk of Malignancy Index (RMI); Risk of Ovarian Malignancy Algorithm (ROMA); Ovarian Neoplasms. Original articles, clinical trials, reviews, systematic reviews and meta-analyses, published between January 2000 and November 2020, were selected to determine the usefulness (among others) of CA 125 and HE4 antigen in ovarian cancer. Results: Finally, 39 transcendental publications were selected to write this article to determine the usefulness of tumour markers and algorithms in ovarian cancer. Conclusions: The usefulness of the tumour markers antigen CA125 and antigen HE4 individually or as a basis for decision-making algorithms has low specificity; however, there is little evidence that confirms their usefulness as markers in ovarian cancer screening. |
format | Online Article Text |
id | pubmed-8624892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86248922021-11-27 Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature Elorriaga, Miguel Ángel Neyro, José Luis Mieza, Jon Cristóbal, Ignacio Llueca, Antoni J Pers Med Review Background: Ovarian cancer has a low incidence, but high mortality due to a habitual diagnosis in advanced cancer stages. Currently, used biomarkers have good sensitivity, but low specificity. Aim: To determine the usefulness of the biomarkers and algorithms used up to now in the screening, diagnosis, response to treatments and identification of recurrence in patients with ovarian masses. Methodology: Systematic search of publications in English in the Medline-PubMed database with the terms: “biomarkers”, “tumour”, “tumour biomarkers”, “marker”, “tumour marker”, “ovarian cancer”, “ovarian”, “Neoplasms”, “cancer”, CA-125 Antigen; Human Epididymis-specific Protein E4; Risk of Malignancy Index (RMI); Risk of Ovarian Malignancy Algorithm (ROMA); Ovarian Neoplasms. Original articles, clinical trials, reviews, systematic reviews and meta-analyses, published between January 2000 and November 2020, were selected to determine the usefulness (among others) of CA 125 and HE4 antigen in ovarian cancer. Results: Finally, 39 transcendental publications were selected to write this article to determine the usefulness of tumour markers and algorithms in ovarian cancer. Conclusions: The usefulness of the tumour markers antigen CA125 and antigen HE4 individually or as a basis for decision-making algorithms has low specificity; however, there is little evidence that confirms their usefulness as markers in ovarian cancer screening. MDPI 2021-10-29 /pmc/articles/PMC8624892/ /pubmed/34834467 http://dx.doi.org/10.3390/jpm11111115 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Elorriaga, Miguel Ángel Neyro, José Luis Mieza, Jon Cristóbal, Ignacio Llueca, Antoni Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title_full | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title_fullStr | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title_full_unstemmed | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title_short | Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature |
title_sort | biomarkers in ovarian pathology: from screening to diagnosis. review of the literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624892/ https://www.ncbi.nlm.nih.gov/pubmed/34834467 http://dx.doi.org/10.3390/jpm11111115 |
work_keys_str_mv | AT elorriagamiguelangel biomarkersinovarianpathologyfromscreeningtodiagnosisreviewoftheliterature AT neyrojoseluis biomarkersinovarianpathologyfromscreeningtodiagnosisreviewoftheliterature AT miezajon biomarkersinovarianpathologyfromscreeningtodiagnosisreviewoftheliterature AT cristobalignacio biomarkersinovarianpathologyfromscreeningtodiagnosisreviewoftheliterature AT lluecaantoni biomarkersinovarianpathologyfromscreeningtodiagnosisreviewoftheliterature |